NYU is 1st Actively Enrolling Site for ONC201 in Adults With Recurrent H3 K27M High-grade Glioma Trial - 102191

Spotlight
Video

NYU is 1st Actively Enrolling Site for ONC201 in Adults With Recurrent H3 K27M High-grade Glioma Trial

Cancer-News has 56 videos Subscribe Here

Loading........
Description: Andrew Chi, MD, PhD at NYU Langone Medical Center Explains How NYU is 1st Actively Enrolling Site for ONC201 in Adults With Recurrent H3 K27M High-grade Glioma Trial. Clinical Trial: ONC201 in Adults With Recurrent H3 K27M High-grade Glioma.
Shared By : Cancer-News
Posted on : 03/20/18
Added : 30 days ago
Category : Brain Cancer



Recommended

Nothing found.